Health Catalyst, Inc (HCAT) Dividend History

Company News

• 2024 Research Report: Care Management Solutions Market Projected to Reach USD 67.02 Billion by 2035

  The care management solutions market is expected to grow from $14.88 billion in 2024 to $67.02 billion by 2035, driven by factors like the rise in chronic diseases, adoption of digital health technologies, and supportive government initiatives. The software segment and web-based delivery models currently dominate the market, while cloud-based solutions and services are set to experience the fastest growth.

  GlobeNewswire Inc.

  Featured Companies: CSCO DELL GEHC MCK MDT TDOC UNH
• Time to Play 5 Top-Ranked Stocks With Rising P/E?

  Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include AMC Entertainment (AMC), Exagen (XGN), Health Catalyst (HCAT), CLEAR Secure (YOU) and Applied DNA Sciences (APDN).

  Zacks Investment Research

  Featured Companies: AMC APDN XGN YOU
• Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

  Throughout the last three months, 4 analysts have evaluated Health Catalyst (NASDAQ:HCAT), offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 0 1 0 0 0 1M Ago 1 1 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Health Catalyst, presenting an average target of $13.5, a high estimate of $16.00, and a low estimate of $11.00. Marking an increase of 1.28%, the current average surpasses the previous average price target of $13.33. Understanding Analyst Ratings: A Comprehensive Breakdown A clear picture of Health Catalyst's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Jessica Tassan Piper Sandler Lowers Overweight $14.00 $15.00 Richard Close Canaccord Genuity Maintains Buy $11.00 $11.00 Stan Berenshteyn Wells Fargo Lowers Overweight $13.00 $14.00 Sarah James Cantor Fitzgerald Maintains Overweight $16.00 - Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Health Catalyst. This information provides a snapshot of how analysts ...Full story available on Benzinga.com

  Benzinga
• Why Health Catalyst Stock Rallied Wednesday Morning

  The data analytics specialist delivered results that weren't as bad as investors had feared.

  The Motley Fool